Myasthenia Gravis

Edit Answers
AGPCKUXQLYLTRZMQCPWC CLLCZKSROJFEGLUVBOIX EDDAUIJMHMDNRASHWGNO TLYHHWFFYGTIARCVCKBS YZQZLYYIELRMHJLQTOHD LGGGRWWSCJLGEQEQKVUW CPGOPIIVWEKIYWEJKHGL HNAZPSWROPVTTREKXVTB OEIUIBXOSSOSGWPQHGMW LUDRTACIXDBOZZWFZLXJ IRCRPOSLGCQDEYLAIKVZ NODBVOIILFBIECQKAAXH EMBANUDMSOCRVSCOTEGQ SULMPYDLMOKYHEYAJWZG TSJIRYLQNUTPMHWTZXQJ ECZXHODQKANPUUFTIPSC RUNUKCVYIDZEMMATALMG ALSTNASSERPPUSONUMMI SACITQLACETYLCHOLINE ERNRIVDMNBTOBOPSYOJY
1.
Disease in which body’s antibodies attack self-cells and -tissues
2.
Blockage of this neurotransmitter lends to symptoms of muscle weakness
3.
________ junction: Synaptic connection involved with transmission of muscle contraction signals
4.
______ weakness :primary symptom of myasthenia gravis
5.
dropping eyelids seen in ocular myasthenia gravis
6.
Myasthenia _____: life-threatening condition often requiring critical care
7.
inhibition of this enzyme is target for first line treatments
8.
preferred symptomatic treatment
9.
secondary treatment for patients not fully satisfied with symptomatic treatment alone
10.
monoclonal antibody that provides potent alternative therapy